Ep. 238 - Biosecure Act: The Impact & What's Ahead
BioCentury This Week
00:00
Impact of the Biosecure Act on the Biotech Industry
The chapter discusses the conversations sparked among biotech leaders and investors regarding the need for contingency plans in response to US-China geopolitical challenges, putting pressure on CEOs to develop backup plans for working with Chinese CDMOs like Wuxi. It also explores how this situation is prompting industry players to rethink strategies and consider financial implications in light of a tight global CDMO market.
Transcript
Play full episode
